DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Chembio Diagnostics, Inc. (CEMI)
« Back to company indexCEMI Chatter Timeline
Stock Ticker for CEMI
Most Active Tweeters for CEMI
| User | Tweets |
|---|---|
| @ChartMill | 1 |
| @bulletin_en | 1 |
Recent Tweets for CEMI
 |
@bulletin_en Chembio Diagnostics Inc. $CEMI and Its Competitors Contrasting side by side. https://t.co/e8wjBXzvEs May 18th 2019, 2:05pm |
 |
@ChartMill In the last month $CEMI has a been trading in the 6.72 - 7.90 range, which is quite wide. https://t.co/SVj8sLFXcv https://t.co/nYeaOgYG4u May 17th 2019, 8:05pm |
 |
@IncredibleTrade $CEMI WIP .. nice breakout setup ? https://t.co/1v9mVuC27c May 8th 2019, 7:05pm |
 |
@InsiderAlertsIA $CEMI: New Insider Filing on Insider KATHERINE LYON DAVIS: https://t.co/FdLu9YQkYe May 8th 2019, 4:05pm |
 |
@dakotafinancial Chembio Diagnostics Inc to Post Q2 2019 Earnings of -$0.16 Per Share, Dougherty & Co Forecasts $CEMI https://t.co/A1uxMvnymP May 8th 2019, 2:05am |
 |
@StockNewsNow $CEMI Chembio Diagnostics Announces Approval of Dengue Point-of-Care Test by Brazil’s Health Regulatory Agency https://t.co/K6oTQ1ELoc May 7th 2019, 2:05pm |
 |
@ThisLincolnian Brokers Offer Predictions for Chembio Diagnostics Inc’s Q2 2019 Earnings $CEMI https://t.co/EPpaemKptN May 7th 2019, 2:05am |
 |
@StockTraderEdge +19% GAIN in 4 wks for our subscribers who BOUGHT $CEMI, SOLD SHORT $IMMU. Stock SELECTION matters, trend DIRECT… https://t.co/9YsLrptGt0 May 6th 2019, 1:05pm |
 |
@RatingsNetwork Dougherty & Co Sets Chembio Diagnostics Q2 2019 Earnings Estimates at ($0.16) EPS. https://t.co/rl7iP80bCQ $CEMI #CEMI May 6th 2019, 2:05am |
|
@ThisLincolnian Chembio Diagnostics $CEMI Rating Reiterated by Canaccord Genuity https://t.co/XK4dIoBzLl May 5th 2019, 9:05pm |
 |
@CSIMarket $CEMI #stock #StockMarket #ChembioDiagnostics reports on https://t.co/savSNU1XbB In contrast to the forth quarter… https://t.co/4u2yvhQZ9Y May 5th 2019, 1:05am |
 |
@SeekingAlpha $CEMI - Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q1 2019 Results - Earnings Call Transcript https://t.co/Ejgh3Zc0wE May 4th 2019, 7:05am |
|
@ChartMill $CEMI is expected to show a strong growth in EPS. In the coming 2 years, the EPS will grow by 40.25% yearly.… https://t.co/DYUTMTUrLt May 3rd 2019, 7:05pm |
 |
@dispatchtribune Chembio Diagnostics $CEMI Posts Earnings Results https://t.co/Po5azcH78I May 3rd 2019, 11:05am |
 |
@FinZTribune Cortina Asset Management Lifted Its Chembio Diagnostics $CEMI Holding; Lyons Wealth Management Upped Its Holding in… https://t.co/GzsChr8fld May 3rd 2019, 8:05am |
 |
@dailypoliticaln Chembio Diagnostics $CEMI Issues Quarterly Earnings Results, Hits Expectations https://t.co/99Xe0t8HzP May 2nd 2019, 5:05pm |
 |
@confcalltran Chembio Diagnostics Just Filed Its Quarterly Report: d)Loss Per Share:Bas... https://t.co/Rd8PnEAZZb $CEMI May 2nd 2019, 8:05am |
 |
@StockTexts $CEMI Chembio Diagnostics, Inc. SEC Filing: Form 10-Q https://t.co/3jRZnx1k6p May 2nd 2019, 8:05am |
 |
@marketexclusive $CEMI CHEMBIO DIAGNOSTICS, INC. (NASDAQ:CEMI) Files An 8-K Results of Operations and Financial Condition https://t.co/cLVhNIXYK1 May 1st 2019, 5:05pm |
|
@dispatchtribune Zacks: Chembio Diagnostics Inc $CEMI Given $11.38 Average Target Price by Brokerages https://t.co/hcCueMixus April 30th 2019, 7:04pm |
 |
@Stock_News_Now $CEMI: New SEC Filing for CEMI: Form DEF 14A (No. 0001140361-19-008079): https://t.co/w4DpJuJsfW April 30th 2019, 5:04pm |
|
@dailypoliticaln Zacks: Chembio Diagnostics Inc $CEMI Receives Average Rating of “Strong Buy” from Brokerages https://t.co/HItiBD9K3l April 23rd 2019, 2:04am |
 |
@HottestStockNow Upcoming Key Date for $CEMI Shareholders https://t.co/8y87OkQlnJ April 22nd 2019, 7:04pm |
|
@StockNewsNow $CEMI Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019 https://t.co/r0012kSjTB April 22nd 2019, 6:04pm |
 |
@ProVesting $CEMI: Chembio Diagnostics to Report First Quarter 2019 Financial Results …: https://t.co/WOfy71Gawc April 22nd 2019, 5:04pm |
 |
@WeekHerald Chembio Diagnostics $CEMI Upgraded to Buy at ValuEngine https://t.co/MWMczSfArr April 18th 2019, 5:04am |
 |
@TickerReport Chembio Diagnostics $CEMI Rating Increased to Buy at ValuEngine https://t.co/TmqUp7xO7g April 17th 2019, 12:04am |
 |
@BlogYomi Longwood Capital Partners Has Cut Its Chembio Diagnostics $CEMI Stake by $8.22 Million; Roof Eidam & Maycock Decrea… https://t.co/KaqvyBF686 April 16th 2019, 3:04pm |
|
@bulletin_en Chembio Diagnostics Inc $CEMI Short Interest Reduced By 14.19% https://t.co/Tlop7sxCp9 April 15th 2019, 1:04pm |
|
@BlogYomi Meridian Bioscience Inc. $CEMI Comparing side by side https://t.co/edFejELFHt April 12th 2019, 1:04am |
 |
@signaljumper $CEMI target 7.50 checkout the chart that I posted for a while April 11th 2019, 12:04am |
 |
@smallcapwatch RT @risk_averse_: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/BtoJJAMR… April 10th 2019, 5:04pm |
 |
@risk_averse_ $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/UUphIEbYhv April 10th 2019, 5:04pm |
 |
@tzack16 $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/kFJ1h3QCRo April 10th 2019, 11:04am |
 |
@outsider_alerts $CEMI - VOLUME ALERT - 177 x expected rate per minute April 10th 2019, 10:04am |
 |
@AnalystsAnalyst $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/Zqvn4hDDIM April 10th 2019, 9:04am |
 |
@ahighelevation $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/LCzlpDFilU April 9th 2019, 11:04pm |
|
@smallcapwatch RT @ContentCarnivor: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/xnlnU… April 9th 2019, 8:04pm |
 |
@ContentCarnivor $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/JyTOGLDIvG April 9th 2019, 8:04pm |
 |
@ZacksAwareness $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/9G4EO4QQJo April 9th 2019, 4:04pm |
 |
@zackcappsocial $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/IiJvOANtfh April 9th 2019, 1:04pm |
|
@StockNewsNow $CEMI Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil… https://t.co/Z1kOcPaT03 April 9th 2019, 12:04pm |
|
@IncredibleTrade $CEMI Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil… https://t.co/CvZ5myATk8 April 9th 2019, 8:04am |
 |
@TheTradeXchange $CEMI: Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil’s Health Regulatory Agency April 9th 2019, 8:04am |
 |
@TheTruthStudio $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/GeeNHrZATN April 9th 2019, 6:04am |
 |
@zackcapp $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/xpSG8ApgF6 April 8th 2019, 10:04pm |
 |
@InstitutionalZC $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/m23Kx9oDkP April 8th 2019, 10:04pm |
 |
@HowieRegay $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/vf6xCWlYp8 April 8th 2019, 6:04pm |
 |
@mmahotstuff1 What’s in Chembio Diagnostics Inc $CEMI After Decline in Shorted Shares? https://t.co/nGyQQ02wYX April 6th 2019, 1:04pm |
 |
@whatsonthorold2 Chembio Diagnostics Inc $CEMI Sellers Covered 14.19% of Their Shorts https://t.co/ZzaDQyaH3H April 6th 2019, 1:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.